investors / analysts from Vision -- native speakers / native culture - suggests would have been able to access primary documents....
---------------------------------------- Tianning (Tina) Yu, Ph.D. Emerging Markets; China Biotech/Pharma
Tianning (Tina) Yu specializes in investments in the Biotechnology and Pharmaceutical Industries as well as firms operating in the Greater China region. Prior to Vision, she was a senior research scientist at Wyeth BioPharma and worked for Genzyme Biosurgery, Morgan Stanley, and Fidelity Asia Ventures in Hong Kong. She holds a Ph.D. in Chemistry from Princeton University, an M.B.A. from Harvard Business School, and a B.S. from University of Science and Technology of China. Ms. Yu is fluent in Mandarin.
Stuart Bradley (Consultant) Emerging Markets - China
Stuart Bradley specializes in investments in the Greater China region. Prior to joining Vision he worked as an Associate Director in the Investment Banking Department of UBS Securities in Beijing and as an Associate in the Investment Banking Department of HSBC in Hong Kong where he focused on state-owned enterprise restructuring, IPO and M&A transactions. Mr. Bradley completed the Wharton-Lauder dual-degree MBA/MA at the University of Pennsylvania where he graduated with honors. Mr. Bradley is fluent in written and spoken Mandarin and has completed Mandarin language programs at Beijing Normal University with Princeton-in-Beijing and at Tsinghua University with the Inter-University Program for Chinese Language Studies. He has a Bachelor's degree, cum laude, in Physics from Princeton University.